All lobbying filings

Nelson Mullins Riley & Scarborough

Nelson Mullins Riley & Scarborough filed a Q4 report for Anbex, Inc. on January 9, 2026, reporting $15,000 in lobbying income.

Lobbying for Anbex, Inc. · Pharmaceutical Manufacturing

As filed: NELSON MULLINS RILEY & SCARBOROUGH for ANBEX, INC.

All filings by Nelson Mullins Riley & Scarborough · Everything Anbex, Inc. has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 9, 2026

Income

$15,000

What the client paid this registrant for the period.

Client based in

Maryland

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Medical/Disease Research/Clinical Labs

Stockpile potassium iodide to counteract effects of nuclear radiation.

Energy/Nuclear

The utilization of potassium iodide to protect against nuclear radiation.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.